THE USE OF HALOPERIDOL (SERENASE (R)) IN CHLORPROTIXEN  RESISTANT PATIENTS.
D000065:Accommodation, Ocular; D000293:Adolescent; D000987:Antisocial Personality Disorder; D001714:Bipolar Disorder; D002749:Chlorprothixene; D004827:Epilepsy; D006220:Haloperidol; D006801:Humans; D001523:Mental Disorders; D009497:Neurotic Disorders; D009771:Obsessive-Compulsive Disorder; D020734:Parkinsonian Disorders; D011618:Psychotic Disorders; D014116:Toxicology
D002749:Chlorprothixene; D006220:Haloperidol
ACCOMMODATION, OCULAR; ADOLESCENCE; CHLORPROTHIXENE; EPILEPSY; HALOPERIDOL; MENTAL DISORDERS; NEUROSES, OBSESSIVE COMPULSIVE; PARKINSONISM; PSYCHOSES; PSYCHOSES, MANIC-DEPRESSIVE; SOCIOPATHIC PERSONALITY; TOXICOLOGIC REPORT